These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 907238)

  • 21. Estradiol and testosterone metabolism and production in men with prostatic cancer.
    Meikle AW; Smith JA; Stringham JD
    J Steroid Biochem; 1989 Jul; 33(1):19-24. PubMed ID: 2761263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormonal studies and physical maturation in adolescent gynecomastia.
    Biro FM; Lucky AW; Huster GA; Morrison JA
    J Pediatr; 1990 Mar; 116(3):450-5. PubMed ID: 2137877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antialdosterones: incidence and prevention of sexual side effects.
    de Gasparo M; Whitebread SE; Preiswerk G; Jeunemaître X; Corvol P; Ménard J
    J Steroid Biochem; 1989 Jan; 32(1B):223-7. PubMed ID: 2913412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of low-dose spironolactone on resistant hypertension.
    Engbaek M; Hjerrild M; Hallas J; Jacobsen IA
    J Am Soc Hypertens; 2010; 4(6):290-4. PubMed ID: 21130975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High estrogen in men after injectable testosterone therapy: the low T experience.
    Tan RS; Cook KR; Reilly WG
    Am J Mens Health; 2015 May; 9(3):229-34. PubMed ID: 24928451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spironolactone and endocrine dysfunction.
    Ann Intern Med; 1976 Nov; 85(5):630-6. PubMed ID: 984618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sprironolactone-induced gynecomastia].
    Keil-Kuri E; Marshall M
    Z Allgemeinmed; 1972 Jul; 48(19):896-7. PubMed ID: 4640137
    [No Abstract]   [Full Text] [Related]  

  • 28. Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
    Dupont A
    Lancet; 1985 Sep; 2(8457):731. PubMed ID: 2863716
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of spironolactone on blood pressure in subjects with resistant hypertension.
    Chapman N; Dobson J; Wilson S; Dahlöf B; Sever PS; Wedel H; Poulter NR;
    Hypertension; 2007 Apr; 49(4):839-45. PubMed ID: 17309946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gynecomastia and antihypertensive therapy.
    Mosenkis A; Townsend RR
    J Clin Hypertens (Greenwich); 2004 Aug; 6(8):469-70. PubMed ID: 15308889
    [No Abstract]   [Full Text] [Related]  

  • 31. Measurement of androgen and estrogen receptors in breast tissue from subjects with anabolic steroid-dependent gynecomastia.
    Calzada L; Torres-Calleja J; Martinez JM; Pedrón N
    Life Sci; 2001 Aug; 69(13):1465-9. PubMed ID: 11554608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Drug-induced gynaecomastia.
    Bridgman JF; Buckler JM
    Br Med J; 1974 Aug; 3(5929):520-1. PubMed ID: 4414195
    [No Abstract]   [Full Text] [Related]  

  • 33. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spironolactone-induced gynecomastia.
    Cuculi F; Suter A; Erne P
    CMAJ; 2007 Feb; 176(5):620. PubMed ID: 17325324
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program.
    Greenblatt DJ; Koch-Weser J
    JAMA; 1973 Jul; 225(1):40-3. PubMed ID: 4740303
    [No Abstract]   [Full Text] [Related]  

  • 36. Gynecomastia and impotence: complications of spironolactone therapy.
    Greenblatt DJ; Koch-Weser J
    JAMA; 1973 Jan; 223(1):82. PubMed ID: 4739107
    [No Abstract]   [Full Text] [Related]  

  • 37. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
    Liang JJ; Jolly D; Chan KJ; Safer JD
    Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antihypertensive effect and serum potassium homeostasis: comparison of hydrochlorothiazide and spironolactone alone and in combination.
    Nash DT
    J Med; 1977; 8(5):367-77. PubMed ID: 338851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Male gynecomastia.
    Haynes BA; Mookadam F
    Mayo Clin Proc; 2009 Aug; 84(8):672. PubMed ID: 19648382
    [No Abstract]   [Full Text] [Related]  

  • 40. Spironolactone-induced bilateral gynecomastia in a man detected by SPECT myocardial perfusion imaging.
    Farag AA; Andrikopoulou E; Hage FG
    J Nucl Cardiol; 2017 Apr; 24(2):742. PubMed ID: 27151301
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.